1.
Circulation
; 120(16): 1637-9, 2009 Oct 20.
Artículo
en Inglés
| MEDLINE
| ID: mdl-19841310
Asunto(s)
Arteria Carótida Interna , Estenosis Carotídea/complicaciones , Estenosis Carotídea/diagnóstico , Hemorragia Cerebral/complicaciones , Hemorragia Cerebral/diagnóstico , Imagen por Resonancia Magnética , Anciano , Isquemia Encefálica/complicaciones , Isquemia Encefálica/etiología , Arteria Carótida Interna/diagnóstico por imagen , Arteria Carótida Interna/patología , Estenosis Carotídea/cirugía , Infarto Cerebral/diagnóstico , Infarto Cerebral/etiología , Endarterectomía Carotidea , Humanos , Imagen por Resonancia Magnética/métodos , Masculino , Ultrasonografía
2.
Neurology
; 63(5): 904-6, 2004 Sep 14.
Artículo
en Inglés
| MEDLINE
| ID: mdl-15365146
RESUMEN
The authors investigated the results of PCV chemotherapy within a cohort of 24 patients treated within the EORTC study 26971 on temozolomide chemotherapy in recurrent oligodendroglioma. The genotype of the tumors was assessed with fluorescent in situ hybridization with locus specific probes for the region 1p36. Four of the 24 patients responded (17%). Fifty percent of patients were still free from progression at 6 months and 21% were free from progression at 12 months. Although a clear relation existed between loss of 1p and response to temozolomide chemotherapy, this relation was absent in salvage PCV chemotherapy.